Empego Technologies inc.: federal grants and contributions: 18 agreements; $1.1M value; 1 departments; 6 programs.
Assay record ASY-CA-0OJLBLE0LX · Cite as: Assay Systems, “Empego Technologies inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/empego-technologies-inc/
The company will be able to allow clinical software such as EMRs and PMSs to send questionnaires to Patients to gather data. This data can include symptom summaries, on-going monitoring of treatment progress and side effects, and the ability to automatically populate patient data.
The Firm is undertaking a transformative R&D project to scale its AI-driven health data infrastructure, enhancing interoperability, privacy compliance, and analytics for Canadian pharmacies. The initiative will develop secure APIs, bilingual interfaces, and adaptive data tools that integrate directly into pharmacy systems, enabling streamlined clinical workflows and compliant data exchange to support innovation and improve patient care across Canada.
Data collection platform.
The project will test AI strategies, establish the ideal architecture and achieve quantitative technical objectives in preparation for the implementation of an AI solution.
Improve customer service and data management.
Recommendation system in the medical field.
Software solution to support patient management in the healthcare system.
The project will enable us to hire a young doctor of pharmacy, recently graduated, to contribute to the development of new technologies that will enable pharmacists to adapt to new professional responsibilities. Among other things, the recent graduate will be helping to improve the clinical algorithm database, proactively train customers, and support the firm's growth vision.
The project allows us to hire a young doctor of pharmacy, a recent graduate, so that she can contribute to the development of new technologies that will enable pharmacists to adapt to new professional responsibilities. Among other things, the recent graduate will be helping to improve the clinical algorithm database, proactively train customers, and support the firm's growth vision.
The intern will develop her technical and interpersonal skills.
Development of evidence-based health algorithms.
The intern will have to understand customers’ specific needs, solve problems quickly and ensure customer satisfaction in order to strengthen their commitment to the firm.
The intern will be responsible for understanding specific customer needs, quickly resolving issues, and ensuring customer satisfaction in order to strengthen their commitment to the firm.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The project will support development of intellectual property capacity within the firm.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.